Dr Reddys Laboratories RDY
NYSE RDY
$12.85 +0.34 (+2.68%)
As of: Sep 29, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Raw Materials (2014 - 2017)

Updated

Dr Reddys Laboratories (RDY) posted Raw Materials of $103.9 million for the quarter ended Dec 31, 2017, down 2.4% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Raw Materials (2014 - 2017) Analysis & Trends

As of Mar 31, 2014, Dr Reddys Laboratories' Raw Materials came in at $101.76 million.

  • The figure for the quarter ended Dec 31, 2017 stands as the lowest quarterly Raw Materials since the quarter ended Mar 31, 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Dr Reddys Laboratories 10.44 Bn 9.62 Bn 396.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 103.90 Mn
Sep 30, 2017 106.50 Mn
Dec 31, 2014 122.04 Mn
Mar 31, 2014 99.29 Mn
API Access

Dr Reddys Laboratories Raw Materials API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=raw-materials&ticker=RDY&period=max&api_key=YOUR_API_KEY